825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Market cap: $7.8B (2/09/2026)
Price: $54.98
Vaxcyte Enters Underwriting Agreement for $550 Million Stock Offering
Vaxcyte, Inc. Amends Executive Change in Control Agreements
Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
Material Contracts
Vaxcyte Q2 2025 Financial Results and VAX-31 Vaccine Update
Shareholder votes
Reports First Quarter 2025 Financial Results and Provides Business Update
Changes in Board, Management or Compensation
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Submission Upload
Correspondence